164 related articles for article (PubMed ID: 26999594)
1. IL-6 Signaling in Myelomonocytic Cells Is Not Crucial for the Development of IMQ-Induced Psoriasis.
Klebow S; Hahn M; Nikoalev A; Wunderlich FT; Hövelmeyer N; Karbach SH; Waisman A
PLoS One; 2016; 11(3):e0151913. PubMed ID: 26999594
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
6. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
8. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome.
Rabeony H; Pohin M; Vasseur P; Petit-Paris I; Jégou JF; Favot L; Frouin E; Boutet MA; Blanchard F; Togbe D; Ryffel B; Bernard FX; Lecron JC; Morel F
Eur J Immunol; 2015 Oct; 45(10):2847-57. PubMed ID: 26147228
[TBL] [Abstract][Full Text] [Related]
9. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
[TBL] [Abstract][Full Text] [Related]
10. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
11. TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model.
Vinter H; Langkilde A; Ottosson V; Espinosa A; Wahren-Herlenius M; Raaby L; Johansen C; Iversen L
Exp Dermatol; 2017 Aug; 26(8):713-720. PubMed ID: 27943421
[TBL] [Abstract][Full Text] [Related]
12. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Sah SK; Park KH; Yun CO; Kang KS; Kim TY
Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
[TBL] [Abstract][Full Text] [Related]
13. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Glucocorticoid-induced Leucine Zipper (GILZ) increases susceptibility to Imiquimod-induced psoriasis and involves cutaneous activation of TGF-β1.
Carceller E; Ballegeer M; Deckers J; Riccardi C; Bruscoli S; Hochepied T; Libert C; Pérez P
Sci Rep; 2016 Dec; 6():38825. PubMed ID: 27934944
[TBL] [Abstract][Full Text] [Related]
15. Essential Role of CARD14 in Murine Experimental Psoriasis.
Tanaka M; Kobiyama K; Honda T; Uchio-Yamada K; Natsume-Kitatani Y; Mizuguchi K; Kabashima K; Ishii KJ
J Immunol; 2018 Jan; 200(1):71-81. PubMed ID: 29150564
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Zhang S; Liu X; Mei L; Wang H; Fang F
BMC Complement Altern Med; 2016 Aug; 16(1):334. PubMed ID: 27581210
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
[TBL] [Abstract][Full Text] [Related]
19. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
[TBL] [Abstract][Full Text] [Related]
20. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
